Potential remdesivir‐related transient bradycardia in patients with coronavirus disease 2019 (COVID‐19)
Authors:
Open Access
- 23 February 2021
- journal article
- letter
- Published by Wiley in Journal of Medical Virology
- Vol. 93 (5) , 2631-2634
Abstract
Click on the article title to read more.Keywords
This publication has 7 references indexed in Scilit:
- Remdesivir for the Treatment of Covid-19 — Final ReportNew England Journal of Medicine, 2020
- Diagnostic approaches and potential therapeutic options for coronavirus disease 2019New Microbes and New Infections, 2020
- Risk factors for non-invasive/invasive ventilatory support in patients with COVID-19 pneumonia: A retrospective study within a multidisciplinary approachInternational Journal of Infectious Diseases, 2020
- Quality of adverse event reporting in clinical trials of remdesivir in patients with COVID-19European Journal of Clinical Pharmacology, 2020
- Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future PerspectivesFrontiers in Pharmacology, 2020
- Effectiveness of remdesivir in patients with COVID-19 under mechanical ventilation in an Italian ICUJournal of Antimicrobial Chemotherapy, 2020
- Increased CD4/CD8 ratio as a risk factor for critical illness in coronavirus disease 2019 (COVID-19): a retrospective multicentre studyInfectious Diseases, 2020